cover
Contact Name
-
Contact Email
-
Phone
-
Journal Mail Official
japr.editor@gmail.com
Editorial Address
Plot No. 105/42, Opposite electricity sub station, Changorabhata, Raipur (Chhattisgarh), India 492001
Location
,
INDONESIA
Journal of Applied Pharmaceutical Research
Published by Creative Pharma Assent
ISSN : -     EISSN : 23480335     DOI : 10.18231
Core Subject : Health,
Journal of Applied Pharmaceutical Research (JOAPR) is an official publication of Creative Pharma Assent (CPA). It is an open access, peer review online international journal. JOAPR is primarily focused on multiple discipline of pharmaceutical sciences (Pharmaceutics, Pharmaceutical Technology, Biopharmaceutics, Cosmetic Technology, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacognosy and Phytochemistry, Herbal drugs/ formulations, Pharmacology, Pharmaceutical Analysis, Pharmacy Practice, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology of Pharmaceutical Interest) which publish quarterly. JOAPR also includes evaluation of pharmaceutical excipients & their practical application to research & industry based efforts. The aim of the scientific journal, JOAPR is to present a wide area for the current researchers to share their noble works and ideas in terms of the research papers, review articles and short communications. JOAPR only publish the original research works with a definite innovation and novelty after thorough reviewing. The paper must have a suitable and proper scientific background.
Arjuna Subject : -
Articles 533 Documents
Nanosponge-facilitated topical administration of apremilast improves wound healing via prolonged release and diminished inflammation Purnima Rai; Ajay Kumar Singh Rawat
Journal of Applied Pharmaceutical Research Vol. 14 No. 5 (2026)
Publisher : Creative Pharma Assent

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.69857/joapr.v14i5.2277

Abstract

Background: Apremilast, a phosphodiesterase-4 inhibitor with anti-inflammatory activity, has potential for wound management; however, poor aqueous solubility and limited topical retention may reduce its effectiveness. Nanosponge-based gels may enhance local retention and sustained drug release. Methodology: Nine nanosponge gel formulations (NSG1–NSG9) were prepared using varying concentrations of Carbopol 934 and propylene glycol. Formulations were evaluated for homogeneity, pH, viscosity, spreadability, extrudability, and drug content. In vitro release was assessed for 24 h using a Franz diffusion cell. The optimized formulation was evaluated for dermal irritation and wound-healing efficacy in Wistar rats using an excision wound model. Histopathological examination and a three-month stability study were also performed. Results and Discussion: NSG7 showed optimal characteristics, with pH 5.92 ± 0.04, viscosity 9,850 ± 145 cP, spreadability 4.8 ± 0.12 g·cm/s, extrudability 440 ± 8 g, and drug content 99.2 ± 0.4%. Drug release reached 82.19 ± 6.80% at 12 h and 94.97 ± 4.91% at 24 h. NSG7 was non-irritant and enhanced wound contraction, epithelialization, collagen deposition, and tissue remodeling compared with untreated and conventional apremilast gel groups. However, the absence of a drug-free Carbopol 934 vehicle control prevented separation of vehicle- related effects from those of the drug-loaded nanosponge system. Conclusion: NSG7 demonstrated favorable sustained drug release, dermal safety, and promising wound-healing activity. The observed in vivo benefits may reflect combined effects of apremilast- loaded nanosponges. Further studies incorporating a vehicle control and extended preclinical and clinical evaluation are warranted.
Application of spectroscopy for investigating in vitro antibacterial efficacy of silver nanoparticles using aqueous (water) leaf extract of Ocimum tenuiflorum Dhani Ram Deka; Pranjoli Das; Songeeta Singha; Manash Pratim Sarma
Journal of Applied Pharmaceutical Research Vol. 14 No. 5 (2026)
Publisher : Creative Pharma Assent

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.69857/joapr.v14i5.2279

Abstract

Background: Silver nanoparticles (AgNPs) have emerged as a promising technique due to their exceptional catalytic, optical, electronic, antimicrobial, and magnetic properties. Herbal formulations of Ocimum tenuiflorum have been reported to possess a broad range of pharmacological activities. Synthesizing AgNPs using plant extracts is environmentally friendly, as the extracts act as both reducing and capping agents during nanoparticle formation. Methodology: We evaluated biosynthesized AgNPs for antibacterial potential against food-borne pathogenic bacteria. Results and Discussion: The study characterized the synthesized AgNPs from Ocimum tenuiflorum leaf extract, and TEM, FTIR, and UV-vis spectroscopy confirmed their morphology and functional groups. This work also observed that AgNP effects increased with dose, indicating a dose-responsive pattern, with maximum inhibition at 100 µl. However, even the lowest AgNP dose (20 µl) outperformed the control plant extract, suggesting that the nanoparticles played a crucial role in enhancing antibacterial efficacy. Conclusion: Biosynthesized AgNPs from Ocimum tenuiflorum showed significantly higher (p < 0.05) antimicrobial activity against E. coli, S. aureus, and P. aeruginosa than the leaf extract, highlighting their potential application in food safety.
Evaluation of antimicrobial activity of balanites aegyptiaca leaf extracts using different solvent systems Vikram Thakkar; Prashat Kumar Dhakad
Journal of Applied Pharmaceutical Research Vol. 14 No. 5 (2026)
Publisher : Creative Pharma Assent

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.69857/joapr.v14i5.2355

Abstract

Background: The rapid rise of antimicrobial resistance poses a serious threat to global healthcare systems, creating an urgent demand for new and effective treatment options. Natural products, particularly those derived from plants, are increasingly being explored as promising sources of antimicrobial agents due to their wide range of bioactive constituents. This study aimed to evaluate the antimicrobial potential of leaf extracts of Balanites aegyptiaca prepared using various solvents against selected bacterial and fungal strains. Methodology: Dried leaf material was extracted using a Soxhlet apparatus with methanol, acetone, benzene, and ethyl acetate. The antimicrobial activity of each extract was assessed through the agar well diffusion method. Both Gram-positive and Gram-negative bacteria, along with selected fungal species, were tested at different concentrations to determine inhibitory effects. Benzene was evaluated purely as an analytical reference for comparative extraction and is not recommended for routine biological or pharmaceutical applications. Results and Discussion: All extracts showed dose-dependent antimicrobial activity. The methanolic extract exhibited the strongest antibacterial effect, producing inhibition zones up to 25.2 mm against Escherichia coli and 16.1 mm against Pseudomonas aeruginosa, along with notable effects on Salmonella typhi and Bacillus subtilis. The ethyl acetate extract demonstrated better activity against Staphylococcus aureus. In antifungal evaluation, methanol and ethyl acetate extracts effectively inhibited Aspergillus niger and Fusarium moniliforme, with maximum zones of 15.7 mm. The observed antimicrobial activity may be associated with the presence of diverse phytochemicals previously reported in Balanites aegyptiaca, including flavonoids, phenolic compounds, tannins, saponins, alkaloids, and phytosterols. Conclusion: The findings indicate preliminary in vitro antimicrobial activity of Balanites aegyptiaca leaf extracts, with the methanolic extract showing the most consistent activity across the tested organisms. These results support further investigation but do not establish therapeutic efficacy or replacement of conventional antimicrobial agents.
In silico design and evaluation of 1,2,4-triazole derivatives as potential gabaa receptor anxiolytics Soniya Satpute; Suvarna Katti; Arshu Patel; Prathamesh Kothawade; Snehal Pawar
Journal of Applied Pharmaceutical Research Vol. 14 No. 5 (2026)
Publisher : Creative Pharma Assent

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.69857/joapr.v14i5.2375

Abstract

Background: The 1,2,4-triazole scaffold is a highly versatile heterocycle widely explored in medicinal chemistry due to its broad spectrum of biological activities, including anxiolytic, antifungal, and anticancer effects. Its structural adaptability makes it a valuable framework for central nervous system (CNS) drug design. Methodology: A virtual library of forty structurally diverse 1,2,4-triazole derivatives (S1–S40) was rationally designed. Biological activity prediction was carried out using PASS, while pharmacokinetic properties were assessed via Swiss-ADME and toxicity profiles through ProTox-II. Molecular docking studies were performed against the human synaptic GABAA receptor (PDB ID: 6D6U) using AutoDock Vina in the PyRx platform. Results and Discussion: All compounds complied with Lipinski’s Rule of Five and exhibited high gastrointestinal absorption. Many derivatives showed blood–brain barrier permeability and CYP1A2 inhibition potential. PASS analysis indicated predominant anxiolytic, insulysin inhibitory, antiseborrheic, and neuropeptide Y2 antagonistic activities. Docking results revealed that compounds S11 (−8.7 kcal/mol) and S3 (−8.3 kcal/mol) demonstrated stronger binding affinity than diazepam (−7.7 kcal/mol), forming key interactions with SER, TYR, PHE, HIS, and MET residues. The favorable ADME, toxicity, and docking profiles suggest strong CNS drug-likeness and receptor compatibility. Enhanced binding interactions compared to the standard drug highlight the potential of these derivatives as effective GABAA modulators. Conclusion: The studied 1,2,4-triazole derivatives represent promising lead candidates for anxiolytic drug development, meriting further experimental validation.
Transforming modern drug discovery with molecular modeling and artificial intelligence Nidhi Gairola; Praveen Kumar; Meenu Chaudhary
Journal of Applied Pharmaceutical Research Vol. 14 No. 5 (2026)
Publisher : Creative Pharma Assent

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.69857/joapr.v14i5.2390

Abstract

Background: Techniques such as Molecular Modeling and Artificial Intelligence in drug discovery have revolutionized the field by improving target identification, virtual screening, lead optimization, and toxicity prediction. Although many computational techniques exist, the literature offers few systematic, comprehensive reviews of molecular modeling combined with AI-driven techniques. This article evaluates the application of molecular modeling technologies, such as Quantum Mechanics, Molecular Mechanics, Molecular Dynamics, molecular docking, and computer-aided drug design, using AI methods. Methodology: The author conducted a narrative review based on published information from scientific literature databases such as PubMed, Scopus, Web of Science, ScienceDirect, and Google Scholar. Results and Discussion: Molecular modeling enables structural and mechanistic models of ligand–target binding, while AI accelerates virtual screening, de novo molecular design, ADMET prediction, and lead optimization. Novel technologies such as AlphaFold, graph neural networks, and generative AI are expanding applied computational drug design. Nevertheless, several challenges remain, including data quality, model interpretability, external validation, dataset bias, overfitting, limited experimental validation, and translational reliability. Conclusion: Integrating molecular modeling and AI technologies represents a major step toward faster, more economical drug discovery processes. Future success will depend on increased use of standardized datasets, the development of explainable AI, and thorough experimental validation.
Design, optimization and biological assessment of leucas aspera phytosomes Rajeshwar Thatipally; Ram Mohan Manda
Journal of Applied Pharmaceutical Research Vol. 14 No. 5 (2026)
Publisher : Creative Pharma Assent

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.69857/joapr.v14i5.2393

Abstract

Background: Leucas aspera (LA) is poorly soluble in water and has a low oral bioavailability, despite its strong antioxidant and hepatoprotective characteristics. Methodology: Phytosomes were prepared by the solvent evaporation method. Phytochemical screening and in vitro antioxidant evaluations were conducted on LA ethanolic leaf extract utilizing DPPH and hydrogen peroxide scavenging tests. The three-level Box-Behnken design was used to determine the drug-to-phospholipid ratio, reaction temperature, and reflux time as independent variables in the optimization of LA-loaded phytosomes (LA-PPS). Results and Discussion: Nano-sized vesicles about 137.76 ± 3.26 nm diameter, a high (i.e., 82.15 ± 0.23 %) entrapment efficiency (EE), a low polydispersity index, and an appropriate zeta potential of approximately -25.36 mV; the F1 formulation showed good stability. The effective complexation and conversion of LA into an amorphous, molecularly distributed state inside the phospholipid matrix was validated by physicochemical characterization using FTIR, DSC, XRD, and SEM. Following non-Fickian diffusion kinetics, the F1 formulation showed substantially enhanced drug solubility in water and prolonged drug release, with an accumulation of almost 82.15 ± 0.23 % over 24 h. Optimized LA-PPS showed better hepatoprotective efficacy than plain LA extract, restored antioxidant enzyme levels, decreased lipid peroxidation, and considerably normalized liver function indicators in an in vivo study using a CCl₄-induced hepatotoxicity rat model. Conclusion: The results indicate that the optimized LA phytosomal formulation (i.,e F1 shows promising results as a nanocarrier for improving the therapeutic effectiveness of Leucas aspera (LA) in hepatic diseases. The method significantly increased the oral bioavailability (BA) of LA, as evidenced by pharmacokinetic evaluation.
Global impact of liver diseases and Rhus chinensis Mill.: A comprehensive review from phytochemistry, hepatoprotection to possible hepatocellular carcinoma prevention Surabhi Mandal; Faruk Alam; Bhupendra Shrestha
Journal of Applied Pharmaceutical Research Vol. 14 No. 5 (2026)
Publisher : Creative Pharma Assent

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.69857/joapr.v14i5.2541

Abstract

Background: Hepatic ailments, notably cirrhosis and chronic liver disease, impose a significant and growing global burden. The intent of this review is to methodically gather and carefully analyze the evidence that is currently available about the hepatoprotective properties of Rhus chinensis Mill. and its probable applications in HCC risk prevention by targeting hepatic precursor pathways. Methodology: This review summarizes recent research on the plant and its hepatoprotective roles by carefully analyzing its documented traditional knowledge and experimental information from 81 scrutinized published articles. Results and Discussion: Phytochemical characterization and ethnopharmacological data suggest that phenolics, flavonoids, tannins, organic acids, and fatty acids are abundant in Rhus chinensis Mill. fruits. Through the modulation of AMPK/PPAR-α, CYP2E1, SREBP-1/FAS,  NF-κB, and cytokines (TNF-α, IL-1β, IL-6), Bcl-2/Bax, and TGF-β/α-SMA in several in vitro/in vivo liver-injury models, the extracts consistently reduced ALT/AST, lipid peroxidation (MDA), and restored antioxidant defenses (GSH, SOD, CAT). This also attenuated inflammatory, fibrogenic, metabolic, and apoptotic pathways, demonstrating its potent hepatoprotective properties. These interdisciplinary effects are consistent with well-established hepatocarcinogenesis biology. The oxidative/nitrosative stress drives genomic instability, DNA adduct formation, and thus malignant transformation. Conclusion: The plant is scientifically evidenced as an excellent hepatoprotective candidate with remarkable antioxidant potential. The hepatoprotective and antioxidant roles of this plant position it as a candidate for future pre-clinical HCC prevention models. Direct in vivo and in vitro anti-HCC data are unavailable, and the current evidence is strictly limited to non-malignant hepatoprotection; thus, the proposed anti-HCC efficacy remains speculative until validated by future research.
Zinc and selenium supplementation mitigates depression like behaviors in rats Abhishek Bhatt; Himani Dumka; Deepika; Jyoti Joshi; Lata Bisht; Veerma Ram
Journal of Applied Pharmaceutical Research Vol. 14 No. 5 (2026)
Publisher : Creative Pharma Assent

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.69857/joapr.v14i5.2557

Abstract

Background: Zinc (Zn) and selenium (Se) act as trace elements essential for neuronal health, and deficiencies in either are linked to mood disorders. Both Zn and Sodium selenate (Na₂SeO₄) have shown emerging potential as antidepressant or mood-modulating agents, primarily through their neuroprotective, antioxidant, and neurochemical regulatory roles. The purpose of the current study was to examine the antidepressant properties of sodium selenate and zinc in albino rats. Here, we investigated the percentage of oxidative and antioxidant, monoamine, and monoamine oxidase (MAO) activities in the rat brain in order to grasp the likely mechanism of zinc and sodium selenate's antidepressant-like action in the tail suspension test (TST) and forced swimming test (FST). Methodology: The antidepressant activity of the mentioned substances was analyzed using modified TST and FST. Na₂SeO₄ (0.4 mg/kg ip), zinc chloride (ZnCl₂) (20 mg/kg ip), and a combination of ZnCl₂ and Na₂SeO₄ were chosen for testing over 14 days. Intraperitoneal administration of imipramine (15 mg/kg) was used as the standard reference antidepressant. Results and Discussion: In comparison to the control group, concurrent administration of ZnCl₂ and Na₂SeO₄ in the current study resulted in a significant decrease in immobility time and an increase in swimming behavior, suggesting a strong antidepressant-like effect. The possible mechanism for this activity may involve modulation of central monoaminergic neurotransmission, evidenced by a probable elevation in monoamine levels within prominent regions such as the hippocampus, cortex, striatum, and hypothalamus. Conclusion: These findings suggest that the combined administration of ZnCl₂ and Na₂SeO₄ may exhibit antidepressant-like effects, highlighting their potential utility as adjunctive agents in the management of depressive disorders.
Development and validation of a stability-indicating UHPLC–MS/MS method for simultaneous quantification of bupropion, hydroxybupropion, sertraline and desmethylsertraline: application to forced degradation studies Shaik Meharaj; Badri Sireesha; Saravanan Ravindiran
Journal of Applied Pharmaceutical Research Vol. 14 No. 5 (2026)
Publisher : Creative Pharma Assent

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.69857/joapr.v14i5.2562

Abstract

Background: Bupropion and sertraline, together with their major metabolites hydroxybupropion and desmethylsertraline, require reliable simultaneous determination for pharmaceutical quality control, stability assessment, and analytical characterization. Methodology: A rapid UHPLC–ESI–MS/MS method was developed using an Acquity UPLC BEH C18 column. The mobile phase consisted of 5 mM ammonium formate in water containing 0.1% formic acid and acetonitrile containing 0.1% formic acid. Detection was performed by multiple reaction monitoring in positive electrospray ionization mode. The method was validated for specificity, linearity, accuracy, precision, sensitivity, robustness, and solution stability according to applicable ICH Q2(R2) analytical validation principles. Forced degradation was evaluated under acidic, alkaline, oxidative, thermal, photolytic, and neutral hydrolytic conditions. Results and Discussion: All four target analytes were selectively detected within a 10-min run time, with no significant interfering responses observed at their respective retention times. Oxidative stress produced the greatest loss of intact analyte, whereas thermal and neutral hydrolytic conditions caused comparatively lower degradation. Selective parent-analyte monitoring under stressed conditions supported the applicability of the quantitative method. Conclusion: The validated method is rapid, sensitive, accurate, and suitable for pharmaceutical quality control, assay determination, stability studies, and forced-degradation assessment of the investigated compounds.
Virtual screening, molecular dynamics, and preliminary in vitro validation of losartan as a potential ZEB1-targeting compound in cancer Poongothai Sundramoorthy; Gayathri Kumararaja
Journal of Applied Pharmaceutical Research Vol. 14 No. 5 (2026)
Publisher : Creative Pharma Assent

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.69857/joapr.v14i5.2584

Abstract

Background: An essential transcription factor linked to tumor growth, the epithelial–mesenchymal transition (EMT), metastasis, and treatment resistance in a number of malignancies is zinc finger E-box-binding homeobox 1 (ZEB1). By virtually screening FDA-approved medications, the current study sought to find possible ZEB1-targeting compounds and assess the main candidate's biological activity in TNBC cells. Methodology: ZEB1 was screened against around 30,000 FDA-approved medications using molecular docking. Molecular dynamics (MD) simulations & protein–ligand interaction tests were used to examine the top-ranked molecule further in order to assess binding stability. MDA-MB-231 cells were employed for preliminary biological validation using the MTT cytotoxicity assay and quantitative RT-PCR measurement of ZEB1 expression. Results and Discussion: Losartan demonstrated the highest docking affinity toward ZEB1 among the investigated compounds, with a docking score of −10.9 kcal/mol. The stability of the protein–ligand complex was further supported by molecular dynamics modeling, which demonstrated persistent protein–ligand interactions during the simulation period. MDA-MB-231 cells exhibited concentration-dependent cytotoxicity following Losartan treatment, with an IC50 of 115 µg/mL. Quantitative RT-PCR analysis showed a numerical decrease in normalized ZEB1 mRNA expression in Losartan-treated cells compared with untreated controls, with a fold change of 0.38; however, this difference was not statistically significant (p = 0.5755). Conclusion: The computational findings support the potential interaction of Losartan with ZEB1, while the preliminary in vitro results demonstrated cytotoxic activity, and a numerical change in normalized ZEB1 mRNA expression did not reach statistical significance. This study highlights the potential of drug-repurposing approaches for identifying candidate compounds for further investigation in ZEB1-associated cancer pathways.

Filter by Year

2013 2026


Filter By Issues
All Issue Vol. 14 No. 5 (2026) Vol. 14 No. 4 (2026) Vol. 14 No. 3 (2026) Vol. 13 No. 4 (2025) Vol. 13 No. 3 (2025) Vol. 13 No. 2 (2025) Vol. 13 No. 1 (2025) Vol. 12 No. 6 (2024) Vol. 12 No. 5 (2024) Vol. 12 No. 4 (2024) Vol. 12 No. 3 (2024) Vol. 12 No. 2 (2024) Vol. 12 No. 1 (2024) Vol. 11 No. 5 (2023) Vol. 11 No. 4 (2023) Vol. 11 No. 3 (2023) Vol. 11 No. 2 (2023) Vol. 11 No. 1 (2023) Vol. 10 No. 4 (2022) Vol. 10 No. 3 (2022) Vol. 10 No. 2 (2022) Vol. 10 No. 1 (2022) Vol. 9 No. 4 (2021) Vol. 9 No. 3 (2021) Vol. 9 No. 2 (2021) Vol. 9 No. 1 (2021) Vol. 8 No. 4 (2020) Vol. 8 No. 3 (2020) Vol. 8 No. 2 (2020) Vol. 8 No. 1 (2020) Vol. 7 No. 4 (2019) Vol 7 No 3 (2019) Vol. 7 No. 3 (2019) Vol 7 No 2 (2019) Vol. 7 No. 2 (2019) Vol 7 No 1 (2019) Vol. 7 No. 1 (2019) Vol 6 No 4 (2018) Vol. 6 No. 4 (2018) Vol 6 No 3 (2018) Vol. 6 No. 3 (2018) Vol 6 No 2 (2018) Vol. 6 No. 2 (2018) Vol 6 No 1 (2018) Vol. 6 No. 1 (2018) Vol 5 No 4 (2017) Vol. 5 No. 4 (2017) Vol 5 No 3 (2017) Vol. 5 No. 3 (2017) Vol 5 No 2 (2017) Vol. 5 No. 2 (2017) Vol. 5 No. 1 (2017) Vol 5 No 1 (2017) Vol 4 No 4 (2016) Vol. 4 No. 4 (2016) Vol. 4 No. 3 (2016) Vol 4 No 3 (2016) Vol. 4 No. 2 (2016) Vol 4 No 2 (2016) Vol. 4 No. 1 (2016) Vol 4 No 1 (2016) Vol 3 No 4 (2015) Vol. 3 No. 4 (2015) Vol. 3 No. 3 (2015) Vol 3 No 3 (2015) Vol 3 No 2 (2015) Vol. 3 No. 2 (2015) Vol. 3 No. 1 (2015) Vol 3 No 1 (2015) Vol. 2 No. 4 (2014) Vol 2 No 4 (2014) Vol 2 No 3 (2014) Vol. 2 No. 3 (2014) Vol. 2 No. 2 (2014) Vol 2 No 2 (2014) Vol. 2 No. 1 (2014) Vol 2 No 1 (2014) Vol 1 No 1 (2013) Vol. 1 No. 1 (2013) More Issue